<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Brian L. Claggett | Biostatistician</title>
    <link>https://gasparyan.co/author/brian-l.-claggett/</link>
      <atom:link href="https://gasparyan.co/author/brian-l.-claggett/index.xml" rel="self" type="application/rss+xml" />
    <description>Brian L. Claggett</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><copyright>Â© 2023 Samvel B. Gasparyan</copyright><lastBuildDate>Sat, 27 Aug 2022 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://gasparyan.co/images/icon_hu37ae94fde7f6135a8e8cfd653ea9ade8_11929814_512x512_fill_lanczos_center_2.png</url>
      <title>Brian L. Claggett</title>
      <link>https://gasparyan.co/author/brian-l.-claggett/</link>
    </image>
    
    <item>
      <title>Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER</title>
      <link>https://gasparyan.co/publication/dapa-hf-deliver-pooled/</link>
      <pubDate>Sat, 27 Aug 2022 00:00:00 +0000</pubDate>
      <guid>https://gasparyan.co/publication/dapa-hf-deliver-pooled/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
